AI
| Followers | 65 |
| Posts | 27744 |
| Boards Moderated | 0 |
| Alias Born | 11/23/2016 |
Monday, December 02, 2024 8:24:12 AM
This is the kind of subgroup analysis I have been posting about hoping to see after reviewing the PDD genetic analysis poster, although COL24A1 was not a gene specifically identified out of the 14,150 analysed.
A questions is then if the PDD trial whole blood transcriptomics didn't find the GWAS database COL24A1 gene had any note worthy effect in PDD, but perhaps that gene falls within the 30% non-overlapping gene pathways related to AD.
The result certainly looks promising based on the minimum context available just now.
A questions is then if the PDD trial whole blood transcriptomics didn't find the GWAS database COL24A1 gene had any note worthy effect in PDD, but perhaps that gene falls within the 30% non-overlapping gene pathways related to AD.
The result certainly looks promising based on the minimum context available just now.
The longer we wait, the sooner we will get rich!
